EUCRAF is pleased to announce the names of the speakers of Seminar 3. This Seminar provides information on the registration of blood products, vaccines and ATMPs.

Prof. Dr. Andreas Bechthold from the University of Freiburg and Dr. Gabriele Dallmann, from EUCRAF are the Course Leaders of this seminar.

Dr. Gabriele Dallmann gives a talk on the product class of blood products, speaks on the certification scheme on plasma master file (PMF) and provides information on plasma-derived products as a component of a medical device.

Dr. Christopher Bravery from CAB Ltd gives an overview on ATMPs including an introduction to the product, its regulation and related procedures. He also talks about the topic what is challenging in the development of ATMPs including examples of successfully authorised and failed products.

Dr. Michael Pfleiderer from PEI gives a presentation on the development and regulation of vaccines, the use of the antigen master file and the future regulation of seasonal and pandemic influenza vaccines.

Dr. Jens Vollmar  from GSK talks about the industry perspective and the experience with the recent pandemic influenza. 

Dr. Pfleiderer together with Dr. Vollmar present the famous example for a successful authorisation of a HPV vaccine Cervarix in a tandem talk.